NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RXRG | hg19_v2_chr1_-_165414414_165414433 | -0.10 | 8.5e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.4 | 1.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.4 | 1.3 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.1 | 1.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.1 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.2 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.7 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.7 | GO:0032796 | uropod organization(GO:0032796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.2 | 1.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 1.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |